Background: In patients with lung cancer, positron emission tomography (PET) using fluor-
18-fluorodesoxyglucose (FDG) may be used both to detect extrathoracic metastases (ETM) …

Background. Accurate staging of non–small cell lung cancer is essential for treatment
planning. We evaluated in a prospective study the role of whole-body 2-[18F] fluoro-2-deoxy …

Background: Accurate staging of mediastinal and hilar lymph nodes is a critical factor
determining operability in patients with non-small cell lung cancer (NSCLC). Positron …

Objectives To evaluate the predictive accuracy as well as the rates of false-positive and false-
negative results of CT and positron emission tomography (PET)-fluorodeoxyglucose (FDG) …

To determine the sensitivity, specificity, and accuracy of staging mediastinal nodal disease
in potentially resectable lung cancer using fluorodeoxyglucose–positron emission …

Study objectives This retrospective study of patients who were referred for surgical resection
of non-small cell lung cancer (NSCLC) assessed the accuracy and cost-effectiveness of …

In the past 10 years, positron emission tomography (PET), usually with 18 F-fluoro-2-deoxy-
D-glucose (FDG), has become an important imaging modality in patients with lung cancer …

Study objective To compare the performance of CT, radio-labeled 18 F-fluoro-2-deoxy-D-
glucose positron emission tomography (FDG-PET) blinded to CT, and FDG-PET visually …

Aims and background A meta-analysis of diagnostic test performance was conducted to
compare the results of relevant studies reporting diagnostic accuracy values for mediastinal …

BACKGROUND: To assess the role of flourodeoxyglucose–positron-emission tomography
(FDG-PET) scan in staging patients with nonsmall cell lung cancer (NSCLC). METHODS …